SML2053

Lalistat 2

≥98% (HPLC), lysosomal acid lipase (LAL) inhibitor, powder

• Synonyme(s) : 1-Piperidinecarboxylic acid 4-(1-piperidinyl)-1,2,5-thiadiazol-3-yl ester, Lalistat-2
• Formule empirique (notation de Hill) : C₁₃H₂₀N₄O₂S
• Numéro CAS: 1234569-09-5
• Poids moléculaire : 296.39
• UNSPSC Code: 41106300
• NACRES: NA.77
• MDL number: MFCD31544494
• Assay: ≥98% (HPLC)
• Form: powder

Propriétés

• Nom du produit: Lalistat 2, ≥98% (HPLC)
• Quality Segment: 200
• assay: ≥98% (HPLC)
• form: powder
• color: white to beige
• solubility: DMSO: 2 mg/mL, clear
• storage temp.: 2-8°C
• SMILES string: O=C(N1CCCCC1)OC2=NSN=C2N3CCCCC3
• InChI key: PNYYVHOTXOEBEV-UHFFFAOYSA-N

Description

Application

Lalistat 2 has been used as a lysosomal acid lipase (LAL) inhibitor to study its effects on hypoxia-inducible factor (HIF) in mice. It has also been used as a LAL inhibitor to study LAL activity on dried blood spot cards.

Biochem/physiol Actions

Lalistat-2 is a potent and specific competitive inhibitor of the lysosomal acid lipase (LAL/Lipa). Lalistat-2 affects lipid droplets morphology and localization.

potent and specific competitive inhibitor of the lysosomal acid lipase (LAL/Lipa).

Informations sur la sécurité

• Classe de stockage: 11 - Combustible Solids
• Que se passe-t-il ?: WGK 3
• Point d'éclair (°F): Not applicable
• Point d'éclair (°C): Not applicable
• Pictogrammes: GHS07
• Mot-clé: Warning
• Codes de danger: H302
• Mentions de précaution: P264 - P270 - P301 + P312 - P501
• Hazard Classifications: Acute Tox. 4 Oral